RecruitingPhase 1 / Phase 2NCT06121297
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Sponsor: Cabaletta Bio
Boston, MA · +18 more sites
Lupus clinical trials in Boston, MA
9 recruiting lupus studies with a site in Boston, MA.
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Boston, MA · +49 more sites
RecruitingPhase 2NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Sponsor: Amgen
Boston, MA · +17 more sites
RecruitingPhase 1 / Phase 2NCT06897930
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Sponsor: AstraZeneca
Boston, MA · +15 more sites
RecruitingPhase 1NCT06925542
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Sponsor: CRISPR Therapeutics
Boston, MA · +8 more sites
RecruitingPhase 1NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Boston, MA · +1 more sites
RecruitingPhase 4NCT07323524
Dapagliflozin in Active Lupus Nephritis
Sponsor: Brigham and Women's Hospital
Boston, MA
RecruitingPhase not listedNCT05934149
Lupus Landmark Study: A Prospective Registry and Biorepository
Sponsor: Lupus Research Alliance
Boston, MA · Worcester, MA · +17 more sites
Not yet recruitingPhase 1NCT07729995
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
Sponsor: Luminary Therapeutics
Boston, MA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.